Halozyme Therapeutics, Inc. (HALO)
Q2 2019 Earnings Conference Call
August 6, 2019 16:30 ET
Company Participants
Albert Kildani - VP, IR & Corporate Communications
Helen Torley - President, CEO & Director
Laurie Stelzer - SVP & CFO
Alison Armour - SVP, R&D
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Jim Birchenough - Wells Fargo
Jason Butler - JMP Securities
Joel Beatty - Citigroup
Presentation
Operator
Good afternoon, everyone. I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr. Kildani, please